EntroGen is a Los Angeles-based biotechnology company primarily focused on molecular diagnostics in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time NGS and PCR-based tests, and many of its products are used to guide and monitor targeted therapies for various malignancies.